Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II

ConditionBone Fracture
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBonusBio Group Ltd

About this trial

The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as an autologous bone-regenerating graft in the reconstruction of deficient bone in two clinical indications:

1. Long and short bone extra-articular comminuted fracture 2. Long and short bones extra and intra articular defect /Gap or non-union, incapable of self-regeneration

Eligibility criteria

Qualifiers

Long and short bones extra articular comminuted fracture or

Long and short bones extra and intra articular defect/gap or non union, incapable of self-regeneration

Disqualifiers

Age is under 18 or above 80

A simple fracture manageable by one definitive treatment

Pregnant or lactating women

Patients with active infection that is in question and needs osteogenic treatment.

Trial design

Treatments tested in this trial

  • BonoFill-II

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators